Locating epileptic foci is critical for surgery in drug-resistant epilepsy. However, conventional methods (MRI, PET, SEEG) often cannot provide sufficient information alone. We have developed a new method, relative oxygen-glucose index (OGI), based on simultaneous PET and calibrated fMRI, which we used as a biomarker to locate epileptic foci during inter-ictal period. Relative OGI reflects aerobic glycolysis relative to global levels, which is useful as many diseases are characterized by metabolic pathway alterations. In this study, we not only demonstrate its potential in foci localization in epilepsy, but also distinguish temporal-lobe and extra-temporal-lobe epilepsy based on their different pathogenesis.
This abstract and the presentation materials are available to members only; a login is required.